Safety and Feasibility of Direct Magnetic Resonance Imaging-guided Transperineal Prostate Biopsy Using a Novel Magnetic Resonance Imaging-safe Robotic Device.
暂无分享,去创建一个
Katarzyna J Macura | Doru Petrisor | Chunwoo Kim | Changhan Jun | Mark W. Ball | D. Stoianovici | D. Petrisor | K. Macura | J. Epstein | M. Allaf | A. Ross | Chunwoo Kim | L. Pan | Jonathan I Epstein | Changhan Jun | Mark W Ball | Ashley E Ross | Kamyar Ghabili | Li Pan | Dan S Stoianovici | Mohamad E Allaf | K. Ghabili | M. Ball
[1] H. Shinmoto,et al. Prostate cancer screening: The clinical value of diffusion‐weighted imaging and dynamic MR imaging in combination with T2‐weighted imaging , 2007, Journal of magnetic resonance imaging : JMRI.
[2] Stephen B. Solomon,et al. MRI-Safe Robot for Endorectal Prostate Biopsy , 2014, IEEE/ASME Transactions on Mechatronics.
[3] Peter H Gann,et al. Risk factors for prostate cancer detection after a negative biopsy: a novel multivariable longitudinal approach. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] Ian M Thompson,et al. Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower. , 2005, JAMA.
[5] D. Stoianovici,et al. Magnetic resonance imaging compatible robotic system for fully automated brachytherapy seed placement. , 2006, Urology.
[6] B. Carey,et al. Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. , 2011, European urology.
[7] Yousef Mazaheri,et al. Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness. , 2011, Radiology.
[8] Ruth Etzioni,et al. Overdiagnosis and overtreatment of prostate cancer. , 2014, European urology.
[9] S. Nour,et al. The impact of multiparametric pelvic magnetic resonance imaging on risk stratification in patients with localized prostate cancer. , 2014, Urology.
[10] H. Haxhimolla,et al. mp-MRI Prostate Characterised PIRADS 3 Lesions are Associated with a Low Risk of Clinically Significant Prostate Cancer - A Retrospective Review of 92 Biopsied PIRADS 3 Lesions , 2015, Current Urology.
[11] M. Terris. Sensitivity and specificity of sextant biopsies in the detection of prostate cancer: preliminary report. , 1999, Urology.
[12] Baris Turkbey,et al. Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. , 2015, JAMA.
[13] Gregory S. Chirikjian,et al. Nonholonomic Modeling of Needle Steering , 2006, Int. J. Robotics Res..
[14] D. Stoianovici,et al. Transperineal prostate intervention: robot for fully automated MR imaging--system description and proof of principle in a canine model. , 2008, Radiology.
[15] P. Carroll,et al. Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower , 2005 .
[16] S. Weigand,et al. Acute urinary retention after transperineal template-guided prostate biopsy. , 2004, International journal of radiation oncology, biology, physics.
[17] Dan Stoianovici,et al. Automatic Brachytherapy Seed Placement Under MRI Guidance , 2007, IEEE Transactions on Biomedical Engineering.
[18] S. Verma,et al. The feasibility of multiparametric magnetic resonance imaging for targeted biopsy using novel navigation systems to detect early stage prostate cancer: the preliminary experience. , 2013, Journal of endourology.
[19] A. Patriciu,et al. A New Type of Motor: Pneumatic Step Motor , 2007, IEEE/ASME Transactions on Mechatronics.
[20] T. Tammela,et al. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up , 2014, The Lancet.
[21] W. Fair,et al. Incidence and clinical significance of false-negative sextant prostate biopsies. , 1998, The Journal of urology.
[22] Aaron Fenster,et al. Magnetic resonance imaging-targeted, 3D transrectal ultrasound-guided fusion biopsy for prostate cancer: Quantifying the impact of needle delivery error on diagnosis. , 2014, Medical physics.
[23] Monish Aron,et al. 3-Dimensional elastic registration system of prostate biopsy location by real-time 3-dimensional transrectal ultrasound guidance with magnetic resonance/transrectal ultrasound image fusion. , 2012, The Journal of urology.
[24] Dan Stoianovici,et al. MR Safe Robot, FDA Clearance, Safety and Feasibility of Prostate Biopsy Clinical Trial , 2017, IEEE/ASME Transactions on Mechatronics.
[25] Kemal Tuncali,et al. Workflow assessment of 3T MRI-guided transperineal targeted prostate biopsy using a robotic needle guidance , 2014, Medical Imaging.
[26] Paul R Young,et al. Systematic transperineal ultrasound-guided template biopsy of the prostate: three-year experience. , 2005, Urology.
[27] L. Salomon,et al. Risk of repeat biopsy and prostate cancer detection after an initial extended negative biopsy: longitudinal follow‐up from a prospective trial , 2013, BJU international.
[28] Kazuro Sugimura,et al. Prostate cancer detection with 3 T MRI: Comparison of diffusion‐weighted imaging and dynamic contrast‐enhanced MRI in combination with T2‐weighted imaging , 2010, Journal of magnetic resonance imaging : JMRI.
[29] Alexandru Patriciu,et al. “MRI Stealth” robot for prostate interventions , 2007, Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy.